{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:45:44Z","timestamp":1789958744683,"version":"4.0.1"},"reference-count":123,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Library","doi-asserted-by":"publisher","award":["000"],"award-info":[{"award-number":["000"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/16078454.2023.2196866","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T17:23:38Z","timestamp":1682011418000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies"],"prefix":"10.1080","volume":"28","author":[{"given":"Salma","family":"Younes","sequence":"first","affiliation":[{"name":"Department of Research, Women\u2019s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar"},{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-856X","authenticated-orcid":false,"given":"Mohamed A.","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Research, Women\u2019s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), Doha, Qatar"},{"name":"School of Life Science, Pharmacy and Chemistry, Faculty of science, engineering &amp; computing, Kingston University London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Al-Jurf","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayah","family":"Ziyada","sequence":"additional","affiliation":[{"name":"College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheyath K.","family":"Nasrallah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palli Valapila","family":"Abdulrouf","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Women\u2019s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Children\u2019s Cancer Hospital Egypt, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Zayed","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Farrell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Sorio","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Morsi","sequence":"additional","affiliation":[{"name":"Quality of Life Unit, National Center for Cancer Care and Research, (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar"},{"name":"Faculty of Health and Social Care Sciences, Kingston University, St. George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Walid","family":"Qoronfleh","sequence":"additional","affiliation":[{"name":"Research &amp; Policy Division, Q3CG Research Institute (QRI), Ypsilanti, MI, USA"},{"name":"21HealthStreet, Consulting Services, London, UK"},{"name":"Applied Biomedicine, Inc., Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-1135","authenticated-orcid":false,"given":"Nader I.","family":"Al-Dewik","sequence":"additional","affiliation":[{"name":"Department of Research, Women\u2019s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar"},{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"},{"name":"College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar"},{"name":"Faculty of Health and Social Care Sciences, Kingston University, St. George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(86)90039-7"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.04.005"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20130067"},{"issue":"2","key":"e_1_3_2_7_1","first-page":"161","article-title":"Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia","volume":"25","author":"Soverini S","year":"2011","unstructured":"Soverini S, Branford S, Nicolini FE, et al. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leukemia. 2011;25(2):161\u2013170.","journal-title":"Leukemia"},{"issue":"1","key":"e_1_3_2_8_1","article-title":"Molecular monitoring of patients with Chronic Myeloid Leukemia (CML) in the state of Qatar: optimization of techniques and response to Imatinib","volume":"2014","author":"Nader A-D","year":"2014","unstructured":"Nader A-D, Andrew J, Yassin MA, et al. Molecular monitoring of patients with Chronic Myeloid Leukemia (CML) in the state of Qatar: optimization of techniques and response to Imatinib. QScience Connect. 2014;2014(1).","journal-title":"QScience Connect"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.36"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1068"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.084145"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1730-1"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152017"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.09.42"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306494"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2010.01054.x"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyab040"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029828"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1990"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327480901600204"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062538"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5486.1938"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1251591"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s12160305"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.5339\/connect.2014.13"},{"key":"e_1_3_2_26_1","author":"Al-Dewik N I E.","year":"2011","unstructured":"Al-Dewik N I E. BCR-ABL Kinase Point Mutations don't Correlate with the Resistance of Chronic Myelocytic Leukemia (CML) to Imatinib Mesylate (IM); A Study on CML Patient Population in Qatar. 2011.","journal-title":"BCR-ABL Kinase Point Mutations don't Correlate with the Resistance of Chronic Myelocytic Leukemia (CML) to Imatinib Mesylate (IM); A Study on CML Patient Population in Qatar"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.5339\/connect.2014.24"},{"key":"e_1_3_2_28_1","author":"Izz EA-DN.","year":"2011","unstructured":"Izz EA-DN. BCR-ABL kinase point mutations don't correlate with the resistance of Chronic Myelocytic Leukemia (CML) to Imatinib Mesylate (IM); a study on CML patient population in Qatar. Qatar Foundation Annual Research Forum Proceedings. 2011.","journal-title":"BCR-ABL kinase point mutations don't correlate with the resistance of Chronic Myelocytic Leukemia (CML) to Imatinib Mesylate (IM); a study on CML patient population in Qatar. Qatar Foundation Annual Research Forum Proceedings"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0076"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402741"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404318"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402741"},{"issue":"1","key":"e_1_3_2_33_1","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010215","article-title":"BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia","volume":"14","author":"Amarante-Mendes G P","year":"2022","unstructured":"Amarante-Mendes G P, Datoguia Rana A. BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics. 2022;14(1).","journal-title":"Pharmaceutics"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294330"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1111"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01732.x"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1142-7"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0772-y"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.129"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8040094"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.8.883"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.03.011"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.02.005"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1466291"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.696960"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-019-00321-z"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918818347"},{"key":"e_1_3_2_48_1","article-title":"Is adherence to Imatinib Mesylate treatment among patients with Chronic Myeloid Leukemia associated with better clinical outcomes in Qatar?","author":"Nader A-D","year":"2016","unstructured":"Nader A-D, Hisham M, Samara Muthanna M. Is adherence to Imatinib Mesylate treatment among patients with Chronic Myeloid Leukemia associated with better clinical outcomes in Qatar?. Clinical Medicine Insights: Oncology. 2016.","journal-title":"Clinical Medicine Insights: Oncology"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.5537.5537"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8111-5"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(76)90160-7"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.1028917"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(76)90160-7"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules190913848"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.507"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000022"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.05.003"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.98"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2016-0103"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018366"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.4137\/BIC.S31427"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4846.4846"},{"key":"e_1_3_2_63_1","author":"Eddin A-DNI.","year":"2011","unstructured":"Eddin A-DNI. Elevation of Alpha Acid Glycoprotein (AGP) does not correlate with the resistance of Chronic Myeloid Leukaemia (CML) to Imatinib Mesylate (IM). 2011.","journal-title":"Elevation of Alpha Acid Glycoprotein (AGP) does not correlate with the resistance of Chronic Myeloid Leukaemia (CML) to Imatinib Mesylate (IM)"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4687"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.166"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-13-1999"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.168"},{"issue":"1","key":"e_1_3_2_68_1","article-title":"A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type \u03b3 in chronic myeloid leukemia patients","volume":"10","author":"Marzia V","year":"2017","unstructured":"Marzia V, Andrea M, Luisa T. A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type \u03b3 in chronic myeloid leukemia patients. Journal of Hematology and Oncology. 2017;10(1).","journal-title":"Journal of Hematology and Oncology"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86875-y"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221140201"},{"key":"e_1_3_2_71_1","author":"Ismail Mohamed . A.","year":"2021","unstructured":"Ismail Mohamed . A. Evaluation of protein tyrosine phosphatase receptor gamma (PTPRG) as a biomarker in chronic myeloid leukaemia patients in the State of Qatar. 2021.","journal-title":"Evaluation of protein tyrosine phosphatase receptor gamma (PTPRG) as a biomarker in chronic myeloid leukaemia patients in the State of Qatar"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1319"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072298"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1319"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146101"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.5427.5427"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102311"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6IB00127K"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-69"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328350012b"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2017.1369022"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.019"},{"key":"e_1_3_2_83_1","first-page":"597","article-title":"MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein","volume":"56","author":"Hershkovitz-Rokah O","year":"2014","unstructured":"Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, etal. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein. Cancer Lett. 2014;56:597\u2013605.","journal-title":"Cancer Lett"},{"key":"e_1_3_2_84_1","article-title":"Expression Profiling of Micro RNAs (MiRNAs) and Long Non-Coding RNAs (lncRNAs) in Chronic Myeloid Leukemia (CML) Patients in the State of Qatar","volume":"130","author":"Nader I","year":"2017","unstructured":"Nader I, Salsabel A-D, Nada Elshami. Expression Profiling of Micro RNAs (MiRNAs) and Long Non-Coding RNAs (lncRNAs) in Chronic Myeloid Leukemia (CML) Patients in the State of Qatar. Blood. 2017;130.","journal-title":"Blood"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1243676"},{"issue":"17","key":"e_1_3_2_86_1","article-title":"Gene expression landscape of chronic myeloid leukemia K562 cells overexpressing the tumor suppressor gene PTPRG","volume":"23","author":"Giulia L","year":"2022","unstructured":"Giulia L, Latorre R. Gene expression landscape of chronic myeloid leukemia K562 cells overexpressing the tumor suppressor gene PTPRG. International Journal of Molecular Sciences. 2022;23(17.","journal-title":"International Journal of Molecular Sciences"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2221-5"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0490-0"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2014.867323"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137093"},{"issue":"4465","key":"e_1_3_2_91_1","article-title":"Treatment-Free remission in chronic myeloid leukemia and new approaches by targeting leukemia stem cells","volume":"11","author":"Chen Y","year":"2021","unstructured":"Chen Y, Zou J, Cheng F, et al. Treatment-Free remission in chronic myeloid leukemia and new approaches by targeting leukemia stem cells. Front Oncol. 2021;11(4465).","journal-title":"Front Oncol"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5871-2"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273979"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5932"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.9123"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26550"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.63"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30094-8"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31411"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32940"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194522"},{"issue":"4","key":"e_1_3_2_104_1","first-page":"458","article-title":"Individualization of drug therapy: history, present state, and opportunities for the future","volume":"92","author":"Lesko LJ","year":"2012","unstructured":"Lesko LJ, Schmidt S. Individualization of drug therapy: history, present state, and opportunities for the future. Clin Pharmacol Ther. 2012;92(4):458\u2013466.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.10.009"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.186"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.176"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2017.40"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31820beb02"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0950"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2596"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02719.x"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0876-0"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.953"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13993-7"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216674"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1229-5"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0732-4"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15215"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology10020118"},{"issue":"3","key":"e_1_3_2_122_1","article-title":"Optimizing clinical workflow using precision medicine and advanced data analytics","volume":"11","author":"Kevin Z","year":"2023","unstructured":"Kevin Z, Mohammad Y, Sawsan M. Optimizing clinical workflow using precision medicine and advanced data analytics. Processes. 2023;11(3).","journal-title":"Processes"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/pr10061107"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3807032"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/16078454.2023.2196866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:02:59Z","timestamp":1702296179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16078454.2023.2196866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/16078454.2023.2196866"],"URL":"https:\/\/doi.org\/10.1080\/16078454.2023.2196866","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2196866"}}